Results 221 to 230 of about 5,134,368 (346)

Universal amplitude ratios for scaling corrections on Ising strips with fixed boundary conditions [PDF]

, 2011
N. Sh. Izmailian
openalex   +1 more source

Mechanical Thrombectomy for TRACE‐III‐Eligible Patients With Ischemic Stroke: A Multicenter Retrospective Study Compared to TRACE‐III and TIMELESS Trials

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The results of the TRACE‐III trial demonstrated that tenecteplase (TNK) might be comparable to TNK combined with mechanical thrombectomy (MT) for large vessel occlusion (LVO) stroke within 4.5 to 24 h of onset, as tested in the TIMELESS trial.
Chongyang Huang, Yanru Liu, Jiangang Zhang, Sheng Guan, Tao Quan, Zhen Chen, Xiaojie Fu, Sen Wei, Kaihao Han, Xiaoan Zhou, Chengcheng Zhu, Edgar Samaniego, Yueqi Zhu, Haowen Xu   +13 more
wiley   +1 more source

ActiveScrollbar: A Scroll Bar with Direct Scale Ratio Control

, 2007
Hongzhi Song, Yu Qi, Lei Xiao, Tonglin Zhu, E.P. Curran   +4 more
openalex   +1 more source

Environmental Load Excess Ratio at the District-Scale in Urban Areas based on the Ecological Footprint Index

, 2008
Takehito Ujihara, Mamoru Taniguchi, Ryoji Matsunaka   +2 more
openalex   +2 more sources

Demonstration of improved heteroepitaxy, scaled gate stack and reduced interface states enabling heterojunction tunnel FETs with high drive current and high on-off ratio [PDF]

, 2012
D. K. Mohata, R. Bijesh, Yunhai Zhu, Mantu K. Hudait, Richard G. Southwick, Z. Chbili, David J. Gundlach, John S. Suehle, J. M. Fastenau, Dmitri Loubychev, A. K. Liu, Theresa S. Mayer, Vijaykrishnan Narayanan, Suman Datta   +13 more
openalex   +1 more source

In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock, Jihyun Park, Dae‐Gyu Jang, Bangyao Zhao, Samuel J. Teener, Ian F. Webber‐Davis, Lili Zhao, Eva L. Feldman, Stephen A. Goutman   +8 more
wiley   +1 more source

Sublethal executioner caspase activation in hepatocytes promotes liver regeneration through the JAK/STAT3 pathway. [PDF]

PLoS Biol
Cao Z, Qin L, Liu K, Yao C, Li E, Hao X, Wang M, Jiang B, Zou Y, Hu H, Liu Q, Shao C, Gong Y, Sun G.   +13 more
europepmc   +1 more source

Detection of regional scale sea-to-air oxygen emission related to spring bloom near Japan by using in-situ measurements of atmospheric oxygen/nitrogen ratio

, 2008
Hiroshi Yamagishi, Yasunori Tohjima, Hirofumi Mukai, K. Sasaoka   +3 more
openalex   +1 more source

Distances and ratios in psychophysical scaling

Acta Psychologica, 1961
openaire   +2 more sources

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li, Binbin Xue, Jia Li, Dewei Xie, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Xu Zhang, Junhui Xia, Jie Lin   +10 more
wiley   +1 more source